Dai Maruyama Selected Research

Dai Maruyama Research Topics

Disease

21	Neoplasms (Cancer) 05/2024 - 07/2012
21	Lymphoma (Lymphomas) 01/2022 - 08/2007
20	Multiple Myeloma 01/2024 - 01/2008
18	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 11/2008
13	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2024 - 01/2009
13	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 11/2008
12	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 05/2007
10	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2024 - 01/2013
9	Disease Progression 05/2024 - 07/2012
9	Hodgkin Disease (Hodgkin's Disease) 10/2020 - 07/2014
7	Infections 05/2024 - 07/2008
6	Febrile Neutropenia 05/2024 - 12/2010
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2024 - 01/2009
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 01/2009
5	Pneumonia (Pneumonitis) 12/2021 - 10/2010
5	Thrombocytopenia (Thrombopenia) 01/2019 - 11/2010
4	Neutropenia 04/2024 - 12/2010
4	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2023 - 03/2016
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2023 - 07/2012
4	Fever (Fevers) 06/2021 - 11/2008
4	Lymphopenia (Lymphocytopenia) 06/2021 - 03/2015
4	Hematologic Neoplasms (Hematological Malignancy) 12/2020 - 08/2007
3	Hepatitis 05/2021 - 09/2015
3	Plasmacytoma 10/2019 - 01/2015
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2017 - 08/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 03/2024
2	Chemotherapy-Induced Febrile Neutropenia 05/2024 - 04/2024
2	Chromosome Aberrations (Chromosome Abnormalities) 08/2023 - 12/2020
2	Hypoalbuminemia 06/2021 - 03/2018
2	Fatigue 03/2018 - 03/2016
2	Opportunistic Infections (Opportunistic Infection) 01/2018 - 11/2008
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2017 - 07/2012
2	Abdominal Pain (Pain, Abdominal) 08/2016 - 05/2007
2	Stomatitis 12/2010 - 11/2010
2	Anemia 12/2010 - 11/2010
2	Leukemia 09/2010 - 08/2007
1	Colorectal Neoplasms (Colorectal Cancer) 04/2024
1	Neuroendocrine Carcinoma 04/2024
1	Prostatic Neoplasms (Prostate Cancer) 03/2024
1	Musculoskeletal Pain 03/2024

Drug/Important Bio-Agent (IBA)

25	Rituximab (Mabthera)FDA Link 05/2024 - 11/2008
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 11/2008
11	Vincristine (Oncovin)FDA LinkGeneric 05/2024 - 11/2008
11	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 11/2008
10	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 11/2008
10	Bortezomib (Velcade)FDA Link 01/2023 - 01/2008
9	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2024 - 02/2024
7	Brentuximab VedotinIBA 12/2023 - 07/2014
6	Monoclonal AntibodiesIBA 01/2024 - 08/2011
6	AntibodiesIBA 09/2022 - 09/2015
5	Dexamethasone (Maxidex)FDA LinkGeneric 06/2021 - 03/2015
4	Prednisone (Sone)FDA LinkGeneric 05/2024 - 01/2019
4	ibrutinibIBA 01/2024 - 12/2016
4	Lenalidomide (CC 5013)FDA Link 12/2023 - 01/2015
4	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 01/2016
4	Antiviral Agents (Antivirals)IBA 05/2021 - 09/2015
4	Epstein-Barr virus encoded RNA 1IBA 07/2019 - 01/2013
4	forodesineIBA 01/2019 - 07/2012
3	venetoclaxIBA 10/2023 - 03/2021
3	Anaplastic Lymphoma KinaseIBA 01/2023 - 07/2012
3	Transaminases (Aminotransferases)IBA 06/2021 - 11/2010
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2021 - 09/2015
3	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 09/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2017 - 03/2015
2	10-propargyl-10-deazaaminopterin FDA Link 03/2024 - 10/2017
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 05/2020
2	mogamulizumabIBA 12/2023 - 12/2020
2	isatuximabIBA 08/2023 - 12/2020
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 08/2018
2	Proteasome InhibitorsIBA 09/2022 - 01/2008
2	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 04/2017
2	Bendamustine Hydrochloride FDA Link 12/2021 - 04/2017
2	pembrolizumabIBA 06/2021 - 11/2020
2	Alanine Transaminase (SGPT)IBA 05/2021 - 03/2018
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2020 - 09/2019
2	LigandsIBA 10/2020 - 05/2018
2	NivolumabIBA 10/2020 - 05/2017
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2016
2	carfilzomibIBA 10/2019 - 10/2018
2	Immunoglobulin M (IgM)IBA 07/2019 - 01/2015
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 12/2010
2	Purine-Nucleoside PhosphorylaseIBA 01/2019 - 01/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2018 - 12/2010
2	Thalidomide (Thalomid)FDA Link 05/2018 - 01/2015
2	SteroidsIBA 08/2016 - 09/2015
2	Vasopressins (Vasopressin)IBA 08/2016 - 05/2007
2	Methotrexate (Mexate)FDA LinkGeneric 10/2015 - 12/2010
1	Therapeutic UsesIBA 05/2024
1	pegylated granulocyte colony-stimulating factorIBA 03/2024

Therapy/Procedure

36	Therapeutics 05/2024 - 11/2008
25	Drug Therapy (Chemotherapy) 05/2024 - 07/2008
7	Stem Cell Transplantation 05/2022 - 08/2016
4	Hematopoietic Stem Cell Transplantation 12/2023 - 09/2010
2	Induction Chemotherapy 05/2021 - 10/2020
2	Autologous Transplantation 10/2020 - 01/2018
2	Immunotherapy 01/2020 - 01/2016
2	Transplantation 01/2018 - 01/2016
2	Cell Transplantation 01/2018 - 08/2007
1	Castration 03/2024
1	Drug Tapering 03/2024